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One of the primary mechanisms to
regulate the effective concentration of
cyclic AMP (cAMP) and cyclic GMP
(cGMP) is through the 30:50-phosphate
bond hydrolysis, which is catalyzed by
cyclic nucleotide phosphodiesterases
(PDEs). Hence, PDEs control the
amount of cAMP and cGMP second
messengers locally available for the
activation of a multitude of down-
stream signaling pathways and, in
turn, for the control of a wide array
of intracellular responses to extracel-
lular stimuli (1–4). Because specific
subtypes or isoforms within the large
PDE superfamily can be selectively in-
hibited, PDEs are also valuable drug
targets. PDE inhibition provides a
means to locally activate cAMP and/
or cGMP-dependent signaling within
particular subcellular microdomains,
with a selectivity that would be chal-
lenging to match through direct activa-
tion of downstream cyclic nucleotide
receptors.
Among the eukaryotic cyclic nucle-
otide receptors, protein kinase A
(PKA) serves as a primary relay of
the cAMP signal and the interplay
between PDEs and PKAs is central to
the tight regulation of signaling in
eukaryotes. The PDE:PKA crosstalk
occurs at multiple levels. It has been
known for over a decade that PDE
and PKA are not only part of coupledhttp://dx.doi.org/10.1016/j.bpj.2014.07.051
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also colocalized to the same subcel-
lular compartments through A-kinase
anchoring proteins (AKAPs) (4). The
combined action of feedback loops
and AKAP-mediated subcellular com-
partmentalization involving specific
PDE and PKA isoforms results in
an exquisitely fine-tuned spatiotem-
poral control of the cAMP signal,
tailored to specific cellular demands
(1–6).
In this issue of the Biophysical Jour-
nal, Krishnamurthy et al. (7) add a new
potential dimension in the complex
PDE:PKA interplay by exploring the
possibility of direct, AKAP-inde-
pendent PDE/PKA interactions as a
complement to AKAP-mediated teth-
ering. Krishnamurthy et al. (7) focused
on the Ia isoform of the regulatory sub-
unit of PKA (RIa), which is known to
bind cAMP with high affinity (Kd ~
nM), and address a long outstanding
question in cAMP signaling: how is
the cAMP signal terminated by PDEs
after cAMP binds RIa and activates
PKA?
When cAMP is sequestered within
PKA R, it is inaccessible to PDEs
and the approximately nM affinity of
RIa for cAMP suggests that, in the
absence of direct interactions between
R and PDEs, signal termination
through PDEs would be kinetically
limited by the very slow off-rate for
the dissociation of cAMP from RIa.
Krishnamurthy et al. (7) propose a
brilliant solution to this paradox by
hypothesizing that PDEs can bind R,
facilitate the dissociation of cAMP
from RIa, and channel the cyclic
nucleotide substrate directly from the
phosphate-binding cassette of RIa to
the active site of the PDE. This hypoth-
esis was inspired by prior work from
the same group on PKA and RegA
in Dictyostelium discoideum (8) and
it is extended here to mammalian
PDEs. For this purpose, Krishnamur-
thy et al. (7) screened several mamma-
lian PDE isoforms for RIa binding,
utilizing fluorescence polarization
measurements and found that RIabinds PDE8A, a close cAMP-selective
PDE homolog of RegA. Although
PKA RIa is likely to directly bind
other PDE isoforms, the PDE8A:RIa
complex was selected for further
biophysical studies. The PDE8A/RIa
interface was mapped using a combi-
nation of peptide arrays, hydrogen/
deuterium exchange mass spectrom-
etry, and computational docking (7).
Although the work of Krishnamur-
thy et al. (7) opens new perspectives
on cAMP signal termination by PDEs,
it also generates additional questions
that must be addressed through further
investigations.
First, it will be critical to fully
probe the existence and functional
relevance of endogenous AKAP-in-
dependent R:PDE interactions in vivo
using, for instance, coimmunoprecipi-
tation methods. Although potential
competition between PDEs and the
endogenous PKA C-subunit for bind-
ing to PKA R is a possible con-
founding complication, these or other
in vivo approaches are also expected
to reveal which R isoforms (Ia, IIa,
Ib, and IIb) bind which PDE sub-
types/isoforms. The PDE-versus-PKA
R selectivity patterns are anticipated
to provide additional means to ratio-
nalize the complex crosstalk between
PKA and PDE. In this respect, we
expect that the contribution of Krish-
namurthy et al. (7) could be an ex-
ample in which biophysics prompts
further investigations in cell biology,
rather than the other way around, as
often observed. If confirmed in vivo,
the work by Krishnamurthy et al. (7)
will reveal a new function of PDEs as
additional anchor proteins for PKA
and it will be interesting to further
dissect the interplay between the
AKAP-mediated and the AKAP-in-
dependent PDE:PKA cross-talk. For
instance, the PKA R:PDE interaction
may also occur in the context of
AKAP complexes. Thus, the anchoring
protein may provide the subcellular
1260 Moleschi and Melacinilocation and limit the range of action
of the PKA R:PDE subcomplex.
Second, whereas the docking
approach taken by Krishnamurthy
et al. (7) was useful to show that the
proposed model for the PDE8A:RIa
complex is structurally viable, accurate
modeling of the PDE:R interactions is
challenging due to the inherent dy-
namic nature of R (3,9), which may
change in conformation upon PDE
binding. Once the PDE8A:RIa in-
terface is accurately mapped, it may
provide a structural rationalization for
the selectivity exhibited by RIa for
different PDE isoforms. Further
structural studies on the PDE8A:RIa
complex will also clarify how these in-
teractions involving PKA affect other
known PDE8A partners, including the
Raf-1 kinase that is also bound to and
regulated by PDE8A (10).
Third, it should be considered that,
although PDE-assisted weakening of
the interactions of cAMP with RIa is
a central part of the model proposed
by Krishnamurthy et al. (7), the mech-
anism underlying the reduction of
cAMP affinity is still not fully under-
stood. In this respect, it will be critical
to reassess the PDE8A:RIa interac-
tions in the context of the allosteric
thermodynamic cycle for cAMP-
dependent control of PKA (9). This cy-
cle arises from the coupling of the
inhibitory and binding equilibria
affecting apo RIa. The apo RIa form
is often neglected because it is only
minimally and transiently populated
in vivo, inasmuch as PKA R is primar-
ily bound to either cAMP or the cata-
lytic subunit of PKA (C). However,
the dynamics of apo RIa is believed
to be a key determinant of the affinitiesBiophysical Journal 107(6) 1259–1260of RIa for cAMP and C, as well as of
PKA activation (9). Apo RIa samples
a dynamic equilibrium of inactive
and active conformations (9). In the
case of the RIa cAMP-binding
domain-A, the free energy landscape
for the apo inhibitory equilibrium is
nearly degenerate, resulting in com-
parable populations of inactive and
active states and in maximal sen-
sitivity to state-selective interactions,
such as those with cAMP or C (9).
Whereas cAMP selectively stabilizes
the active conformation of RIa, C pref-
erentially binds the inactive state of
RIa.
One hypothesis to explain how
PDE8A reduces the affinity of cAMP
for RIa is to assume that PDE8A, simi-
larly to C, selectively binds the inactive
conformation of RIa, thus reducing
the effective population of the active
state, which binds cAMP with high
affinity. As of this writing, this hy-
pothesis is purely speculative, and
may not capture the full complexity
of PDE:PKA interactions, which may
also cause currently uncharacterized
structural perturbations. Overall, the
work by Krishnamurthy et al. (7) is
an important contribution to the field
of cAMP signaling and opens new
perspectives to understand how PDEs
terminate and modulate the cAMP
signal in time and space, both in an
AKAP-dependent and independent
manner.We thank Professor John D. Scott, University
of Washington, Seattle, WA, for helpful discus-
sions.
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